Sectors
VRAX
Virax Biolabs Group Limited
2.82
1 x 2.39
1 x 3.21
bid
ask
-
0.04
1.40%
1 @ 05:02 PM
2.79 -0.03 (1.06%)
| Ytd | -67.40% | |
| 1y | -81.39% |
2.77
day range
2.92
2.50
52 week range
21.75
| Open | 2.92 | Prev Close | 2.86 | Low | 2.77 | High | 2.92 | Mkt Cap | 2.25M |
| Vol | 16.76K | Avg Vol | 1.82M | EPS | -12.64 | P/E | N/A | Forward P/E | -1.01 |
| Beta | 1.93 | Short Ratio | 0.11 | Inst. Own | 5.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.27 | 200-d Avg | 5.77 | 1yr Est | 20.00 |
| Income Statement | |||
| Weighted Average Shares | 397.59K | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.44M | ||
| Cash and Equivalents (USD) | 6.44M | ||
| Current Assets | 6.83M | ||
| Property, Plant & Equipment Net | 1.50M | ||
| Total Assets | 8.32M | ||
| Debt Current | 109.58K | ||
| Total Debt | 414.39K | ||
| Current Liabilities | 685.02K | ||
| Debt Non-Current | 304.81K | ||
| Total Liabilities | 989.83K | ||
| Accumulated Retained Earnings (Deficit) | -29.61M | ||
| Accumulated Other Comprehensive Income | -310.28K | ||
| Shareholders Equity | 7.58M | ||
| Shareholders Equity (USD) | 7.58M | ||
| Assets Non-Current | 1.50M | ||
| Total Debt (USD) | 414.39K | ||
| Liabilities Non-Current | 304.81K | ||
| Trade and Non-Trade Payables | 575.45K | ||
| Tax Assets | 27.11K | ||